Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

COVID-19

  • Home
  •  
  • COVID-19



  • Most Read
  • Latest Comments
  • RATs – The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • RATs – The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • RATs – The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • RATs – The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • RATs – The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • Lumos Diagnostics expands FebriDx distribution to Belgium
    Lumos Diagnostics expands FebriDx distribution to Belgium
    • News

  • AD1 secured contract extension with NSW Government for recruitment tech
    AD1 secured contract extension with NSW Government for recruitment tech
    • News

  • Federal budget’s funding boost for HIV self-testing kit ups Atomo Diagnostics morale
    Federal budget’s funding boost for HIV self-testing kit ups Atomo Diagnostics morale
    • News

  • Lumos completes phase 1 of developing premature birth detection test
    Lumos completes phase 1 of developing premature birth detection test
    • News

  • RATs – The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
    • News

    RATs – The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy

    With ‘Rapid Antigen Test’ having only taken several days to likely be one of the most commonly used words of 2022, everyone is looking for them but demand is monumentally outweighing supply. With their surge in use, it may only be a matter of time until Australian regulators fast-track approval of more RAT manufacturers with

    Read More
    Public
  • MedAdvisor engaged with $4m deal to promote COVID-19 vaccination
    • News

    MedAdvisor engaged with $4m deal to promote COVID-19 vaccination

    While Australia enjoys the freedom of restrictions opening up and a substantial decrease in the COVID-19 deaths, vaccination rates across various States in the US remain dangerously low which has prompted one big pharma company to engage medtech company MedAdvisor (ASX: MDR) to slay the anti-vaxxers.  For the unnamed big pharma company which has a

    Read More
    Public
  • Uscom releases ventilator calibrator as demand surges through COVID-19
    • News

    Uscom releases ventilator calibrator as demand surges through COVID-19

    To assist with maintenance of ventilator devices being used to combat the coronavirus pandemic, Uscom (ASX: UCM) has released the SpiroSonic VENTITEST ventilator testing device which will allow medical professionals to calibrate ventilators, making it the first digital ultrasonic calibrator of its kind.  With the need for ventilators having risen dramatically as the world grapples

    Read More
    Public
  • Why gold will continue to shine
    • Opinion

    Why gold will continue to shine

    Its not too late to buy precious metals With gold hitting all-time highs across the past week, many investors are asking: ‘have I missed the move?’ While it might seem like buying in now is buying in at the absolute peak, there are many reasons to believe that gold will keep rising. Indeed, the positive

    Read More
    Public
  • IPO Watch August: 4D Medical
    • News

    IPO Watch August: 4D Medical

    While the number of companies set to list on the ASX is still quieter than usual, we are continuing to see many healthcare companies viewing COVID-19 as an opportunity to make their public debut.  4D Medical are a Melbourne-based medical technology company, who have spent the last 15 years developing lung imaging software. The ‘software

    Read More
    Public
  • The stocks struggling with Victoria’s rise in cases
    • Opinion

    The stocks struggling with Victoria’s rise in cases

    “The place to be”? Not for many ASX listed stocks who are copping a hit from a second wave of COVID-19 infections across Victoria. US shares have returned to their highest levels since the COVID-19 selling began, but our shares are still a way off that level, with recent underperformance corresponding to the spike in

    Read More
    Public
  • 1
  • 2
  • 3
  • 4
  • 5

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.